These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 20045627)
1. Usefulness of factor II and factor X as therapeutic markers in patients under chronic warfarin therapy. Costa IM; Serralheiro AI; Rodrigues M; Alves G; Falcão AC Biomed Pharmacother; 2010 Feb; 64(2):130-2. PubMed ID: 20045627 [TBL] [Abstract][Full Text] [Related]
2. Oral anticoagulant initiation: rationale for the use of warfarin dosing nomograms. Crowther MA Semin Vasc Med; 2003 Aug; 3(3):255-60. PubMed ID: 15199458 [TBL] [Abstract][Full Text] [Related]
3. Thrombin generation and coagulation factor activities: evaluation and comparison with the international normalized ratio. Christensen TD; Jensen C; Larsen TB; Christiansen K; Sørensen B Blood Coagul Fibrinolysis; 2009 Jul; 20(5):358-65. PubMed ID: 19417631 [TBL] [Abstract][Full Text] [Related]
4. Relationship between international normalized ratio values, vitamin K-dependent clotting factor levels and in vivo prothrombin activation during the early and steady phases of oral anticoagulant treatment. D'Angelo A; Della Valle P; Crippa L; Fattorini A; Pattarini E; Viganò D'Angelo S Haematologica; 2002 Oct; 87(10):1074-80. PubMed ID: 12368163 [TBL] [Abstract][Full Text] [Related]
5. Relationship between chromogenic factor X and international normalized ratio differs during early warfarin initiation compared with chronic warfarin administration. Rosborough TK; Jacobsen JM; Shepherd MF Blood Coagul Fibrinolysis; 2009 Sep; 20(6):433-5. PubMed ID: 19543077 [TBL] [Abstract][Full Text] [Related]
6. Monitoring anticoagulation in patients with an unreliable prothrombin time/international normalized ratio: factor II versus chromogenic factor X testing. Baumann Kreuziger LM; Datta YH; Johnson AD; Zantek ND; Shanley R; Reding MT Blood Coagul Fibrinolysis; 2014 Apr; 25(3):232-6. PubMed ID: 24681704 [TBL] [Abstract][Full Text] [Related]
7. Emergency oral anticoagulant reversal: the relative efficacy of infusions of fresh frozen plasma and clotting factor concentrate on correction of the coagulopathy. Makris M; Greaves M; Phillips WS; Kitchen S; Rosendaal FR; Preston EF Thromb Haemost; 1997 Mar; 77(3):477-80. PubMed ID: 9065997 [TBL] [Abstract][Full Text] [Related]
8. Optimal dose of prothrombin complex concentrate for acute reversal of oral anticoagulation. Yasaka M; Sakata T; Naritomi H; Minematsu K Thromb Res; 2005; 115(6):455-9. PubMed ID: 15792675 [TBL] [Abstract][Full Text] [Related]
9. Therapeutic monitoring of warfarin: the appropriate response marker. Costa IM; Soares PJ; Afonso M; Ratado P; Lanaot JM; Falcão AC J Pharm Pharmacol; 2000 Nov; 52(11):1405-10. PubMed ID: 11186249 [TBL] [Abstract][Full Text] [Related]
10. Contributions of procoagulants and anticoagulants to the international normalized ratio and thrombin generation assay in patients treated with warfarin: potential role of protein Z as a powerful determinant of coagulation assays. Choi Q; Kim JE; Hyun J; Han KS; Kim HK Thromb Res; 2013 Jul; 132(1):e70-5. PubMed ID: 23769659 [TBL] [Abstract][Full Text] [Related]
11. Point-of-care testing of the international normalized ratio in patients with antiphospholipid antibodies. Perry SL; Samsa GP; Ortel TL Thromb Haemost; 2005 Dec; 94(6):1196-202. PubMed ID: 16411394 [TBL] [Abstract][Full Text] [Related]
12. Discrepant sensitivity of thromboplastin reagents to clotting factor levels explored by the prothrombin time in patients on stable oral anticoagulant treatment: impact on the international normalized ratio system. Testa S; Morstabilini G; Fattorini A; Galli L; Denti N; D'Angelo A Haematologica; 2002 Dec; 87(12):1265-73. PubMed ID: 12495900 [TBL] [Abstract][Full Text] [Related]
13. [The application of thrombin generation tests to warfarin anticoagulation monitoring]. Chen HY; Ding QL; Zhang LW; Xu GQ; Dai J; Wang XF; Xi XD; Wang HL Zhonghua Xue Ye Xue Za Zhi; 2008 Mar; 29(3):168-70. PubMed ID: 18788615 [TBL] [Abstract][Full Text] [Related]
14. Effect of oral diuretics on chronic warfarin therapy: a retrospective study. Edwards HD; Webb RD; Conway SE Expert Opin Drug Saf; 2012 May; 11(3):375-80. PubMed ID: 21957964 [TBL] [Abstract][Full Text] [Related]
15. Poor correlation of supratherapeutic international normalised ratio and vitamin K-dependent procoagulant factor levels during warfarin therapy. Sarode R; Rawal A; Lee R; Shen YM; Frenkel EP Br J Haematol; 2006 Mar; 132(5):604-7. PubMed ID: 16445834 [TBL] [Abstract][Full Text] [Related]
16. [Accuracy and reliability of international normalized ratio (INR) in monitoring of warfarin--comparison in the sensitivity to extrinsic coagulation factors between PT (INR) and TT (INR)]. Sakayori T; Naito S; Yoshida M; Kumano O; Kato N; Okuda M; Ieko M Rinsho Byori; 2010 Aug; 58(8):779-85. PubMed ID: 20860170 [TBL] [Abstract][Full Text] [Related]
17. Comparison of a chromogenic factor X assay with international normalized ratio for monitoring oral anticoagulation therapy. McGlasson DL; Romick BG; Rubal BJ Blood Coagul Fibrinolysis; 2008 Sep; 19(6):513-7. PubMed ID: 18685434 [TBL] [Abstract][Full Text] [Related]
18. Unreliability of international normalized ratio for monitoring warfarin therapy in patients with lupus anticoagulant. Rosborough TK; Shepherd MF Pharmacotherapy; 2004 Jul; 24(7):838-42. PubMed ID: 15303447 [TBL] [Abstract][Full Text] [Related]
19. Comparison and evaluation of a Point-of-care device (CoaguChek XS) to Owren-type prothrombin time assay for monitoring of oral anticoagulant therapy with warfarin. Wieloch M; Hillarp A; Strandberg K; Nilsson C; Svensson PJ Thromb Res; 2009 Jul; 124(3):344-8. PubMed ID: 19423152 [TBL] [Abstract][Full Text] [Related]
20. Oral anticoagulant therapy and international normalized ratios in swine. McGlasson DL; Brickey DA; Doe RH Lab Anim Sci; 1998 Aug; 48(4):371-3. PubMed ID: 10090045 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]